Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (241-250 of 621) with videos related to

Pageof 63
Sort By:
Journal of Scleroderma and Related Disorders|November 15, 2024
A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ studyDinesh Khanna, Jeska de Vries-Bouwstra, Anna-Maria Hoffmann-Vold, et al.
Clinical Rheumatology|August 7, 2024
Impact of blue-collar vs. white-collar occupations on disease burden in psoriatic arthritis patients: A Swiss clinical quality management in rheumatic diseases cohort studyNina Colla, Julia-Tatjana Maul, Enriqueta Vallejo-Yagüe, et al.
Expert Review of Clinical Immunology|October 20, 2020
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patientsFrancesco Benvenuti, Elisabetta Zanatta, Jérôme Avouac, et al.
Arthritis Research & Therapy|July 31, 2021
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimodRoger Hesselstrand, Jörg H W Distler, Gabriela Riemekasten, et al.
Investigative Radiology|May 31, 2022
Potential of Photon-Counting Detector CT for Radiation Dose Reduction for the Assessment of Interstitial Lung Disease in Patients With Systemic SclerosisLisa Jungblut, André Euler, Jochen von Spiczak, et al.
RMD Open|September 3, 2021
Patient and healthcare professional eHealth literacy and needs for systemic sclerosis support: a mixed methods studyAgnes Kocher, Michael Simon, Andrew A Dwyer, et al.
Orphanet Journal of Rare Diseases|January 9, 2023
Patient Assessment Chronic Illness Care (PACIC) and its associations with quality of life among Swiss patients with systemic sclerosis: a mixed methods studyAgnes Kocher, Michael Simon, Andrew A Dwyer, et al.
Annals of the Rheumatic Diseases|September 10, 2013
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitorsBritta Maurer, Alfiya Distler, Clara Dees, et al.
Annals of the Rheumatic Diseases|May 24, 2013
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosisClara Dees, Inga Schlottmann, Robin Funke, et al.
The Lancet. Rheumatology|January 24, 2024
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trialsAnna-Maria Hoffmann-Vold, Elizabeth R Volkmann, Yannick Allanore, et al.
Pageof 63

Showing results (241-250 of 621) with videos related to

Sort By:
Pageof 63
Journal of Scleroderma and Related Disorders|November 15, 2024
A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ studyDinesh Khanna, Jeska de Vries-Bouwstra, Anna-Maria Hoffmann-Vold, et al.
Clinical Rheumatology|August 7, 2024
Impact of blue-collar vs. white-collar occupations on disease burden in psoriatic arthritis patients: A Swiss clinical quality management in rheumatic diseases cohort studyNina Colla, Julia-Tatjana Maul, Enriqueta Vallejo-Yagüe, et al.
Expert Review of Clinical Immunology|October 20, 2020
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patientsFrancesco Benvenuti, Elisabetta Zanatta, Jérôme Avouac, et al.
Arthritis Research & Therapy|July 31, 2021
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimodRoger Hesselstrand, Jörg H W Distler, Gabriela Riemekasten, et al.
Investigative Radiology|May 31, 2022
Potential of Photon-Counting Detector CT for Radiation Dose Reduction for the Assessment of Interstitial Lung Disease in Patients With Systemic SclerosisLisa Jungblut, André Euler, Jochen von Spiczak, et al.
RMD Open|September 3, 2021
Patient and healthcare professional eHealth literacy and needs for systemic sclerosis support: a mixed methods studyAgnes Kocher, Michael Simon, Andrew A Dwyer, et al.
Orphanet Journal of Rare Diseases|January 9, 2023
Patient Assessment Chronic Illness Care (PACIC) and its associations with quality of life among Swiss patients with systemic sclerosis: a mixed methods studyAgnes Kocher, Michael Simon, Andrew A Dwyer, et al.
Annals of the Rheumatic Diseases|September 10, 2013
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitorsBritta Maurer, Alfiya Distler, Clara Dees, et al.
Annals of the Rheumatic Diseases|May 24, 2013
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosisClara Dees, Inga Schlottmann, Robin Funke, et al.
The Lancet. Rheumatology|January 24, 2024
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trialsAnna-Maria Hoffmann-Vold, Elizabeth R Volkmann, Yannick Allanore, et al.
Pageof 63